Stoke Therapeutics and Biogen Present New Data at the 54th Child Neurology Society (CNS) Annual Meeting that Support the Potential of Zorevunersen as a Dise…

Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the ...
TipRanks on MSN

Biogen, Stoke Therapeutics present follow-up analyses from zorevunersen studies

Biogen (BIIB) and Stoke Therapeutics (STOK) announced the presentation of longer-term follow-up analyses from the ongoing open-label extension ...
TipRanks on MSN

Stoke, Biogen presents new data from OLE studies of zorevunersen

Stoke Therapeutics (STOK) and Biogen (BIIB) announced the presentation of longer-term follow-up analyses from the ongoing open-label extension ...

US Rep. Edwards hears from constituents about Medicaid, shutdown at 'Mobile Office Hours'

U.S. Rep. Chuck Edwards spoke to his District 11 constituents in Flat Rock, Brevard and Saluda. These are the concerns they ...

Stoke Therapeutics stock rises after appointing Ian Smith as CEO

Investing.com -- Stoke Therapeutics (NASDAQ:STOK) stock rose 7% Monday after the company announced the appointment of Ian F. Smith as its permanent Chief Executive Officer.